ADAI News & Events
December 17, 2025
2025 Highlights from CEDEER
ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) team just sent out a great newsletter recapping all the amazing work they did in 2025! Read all about the ways they partnered with people across Washington State to better: Some of the work the CEDEER team did this year involved: Check out the newsletter…
December 4, 2025
UW Undergrads: Apply for the ADAI Summer Internship! (Deadline Feb 1, 2026)
ADAI is launching a new summer internship program for UW undergraduates in Seattle, Washington interested in working in substance use/addictions, public health, science/health communications, and related fields!
December 2, 2025
Empathy Lens Webinar: Humanizing Images & Education for Reducing Stigma (December 17, 9am PT)
Research has shown that using stigmatizing language and imagery related to people who use drugs perpetuates harmful stereotypes and health barriers among this already vulnerable population. Finding realistic, high-quality images to support information dissemination work is a constant struggle, as many asset collections, including fee-based stock photo sites, largely contain dehumanizing and/or factually incorrect graphics…
December 1, 2025
Congratulations to Dr. Andrew Saxon of the NIDA CTN’s Pacific Northwest Node!
ADAI wants to issue a hearty CONGRATULATIONS to Andrew Saxon, MD, the recipient of the 2025 Outstanding Achievement and Service Award from the American Academy of Addiction Psychiatry (AAAP). [Dr. Saxon is a long-time member of the NIDA Clinical Trials Network’s Pacific Northwest Node, located at ADAI and has been working with many of our staff…
November 20, 2025
Northwest ATTC & FADU Webinar: Meeting Clients Where They Are: Using a Neuro-Informed Lens (Dec. 3, 2025, 12pm PT)
Join the Northwest ATTC on December 3, 2025 (12-1pm PT) for their next webinar, featuring Linda Segur, a professional with over 35 years of experience in human services, specializing in families impacted by substance use, poverty, and mental health issues. This session is co-sponsored by ADAI’s Fetal Alcohol & Drug Unit (FADU). Meeting Clients Where They Are:…
November 6, 2025
RECORDING AVAILABLE: ADAI Virtual Lunch & Learn: Quantifying Cannabis/THC Exposure During Pregnancy
This session was hosted in November 2025. Find the recording here! Quantification and prediction of human fetal THC exposure during pregnancy to inform fetal cannabis toxicity Jashvant (Jash) D. Unadkat, Ph.D.Professor, Dept. of PharmaceuticalsUniversity of Washington Prenatal cannabis use is associated with neurodevelopmental deficits, likely due to exposure to the psychoactive cannabinoid, (-)-Δ9-tetrahydrocannabinol (THC), and…
November 4, 2025
ADAI Virtual Research Open House: Nov. 12 (5:30-7pm PT)
Are you interested in working in substance use / addiction research? Join us on November 12, 2025 (5:30-7pm PT) for our next ADAI Virtual Research Open House! Come hear from ADAI faculty and staff about the wide variety of work we do, including research, implementation, training/education, data science, information services, and more! This event is…
October 17, 2025
New ICD-10-CM Code for Cannabinoid Hyperemesis Syndrome: R11.16
A new ICD-10-CM diagnosis code for Cannabinoid Hyperemesis Syndrome (CHS) went into effect on October 1, 2025. ICD-10-CM codes are used to classify different medical diagnoses, symptoms, and procedures in health records and for billing and claims processing. To date, most health systems have documented CHS using a combination of codes for nausea and vomiting, such…
October 16, 2025
New Videos in the Mental Health Topics for Non-Therapist Professionals Series
The Mental Health Topics for Non-Therapist Professionals series on the LearnAboutTreatment.org website, produced by the ADAI State Opioid Response Training Team, is for providers who work with people with a substance use disorder (SUD) but are not trained as mental health therapists. The goal is to boost knowledge of mental health issues, especially those common…
New Naloxone and Overdose Resources from the WA Department of Health
The WA State Department of Health (DOH) has some new resources out about naloxone and overdose. Issue Brief: The Risks of High-Dose Naloxone Products and Nalmefene for Community Opioid Overdose Response In this issue brief, DOH provides a summary of the current data and their recommendations on opioid overdose reversal medication types and dosages. Key…
Previous page Next page
